GoodRx Holdings (GDRX) Cash from Operations (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Cash from Operations data on file, last reported at 11838000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 25.76% year-over-year to 11838000.0; the trailing twelve-month figure through Mar 2026 stood at 170329000.0 (up 13.01% YoY), and the FY2025 full-year result was 167904000.0, down 8.69% from the prior year.
• Cash from Operations eased to 11838000.0 in Q1 2026, from 32888000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 86862000.0 in Q3 2024 to a low of 9413000.0 in Q1 2025.
• A 5-year average of 38159176.47 and a median of 32888000.0 in 2025 frame the typical range for Cash from Operations.
• Peak annual rise in Cash from Operations reached 411.08% in 2025, while the deepest fall reached 77.9% in 2025.
• Tracing GDRX's Cash from Operations over 5 years: stood at 31879000.0 in 2022, then tumbled by 50.22% to 15868000.0 in 2023, then soared by 181.97% to 44743000.0 in 2024, then declined by 26.5% to 32888000.0 in 2025, then sank by 64.01% to 11838000.0 in 2026.
• Business Quant data shows GDRX's Cash from Operations at 11838000.0 in Q1 2026, 32888000.0 in Q4 2025, and 76023000.0 in Q3 2025.